Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) in People With Post Covid-19 Condition and Emotional Symptomatology.

NCT05581277 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria Aragón as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05581277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) in People With Post Covid-19 Condition and Emotional Symptomatology.
Lead sponsor
Instituto de Investigación Sanitaria Aragón
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2023
Completion date
September 30, 2023
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depressive disorder, emotional disorder, post covid-19 condition